Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 601-610 of 9364

Page
per page
  1. SP2509
    B4894 SP2509
    Target: Histone Demethylases
    Summary: Demethylase 1 (LSD1) antagonist, novel Lysine-specific
      insoluble in H2O; insoluble in EtOH; ≥19.45 mg/mL
  2. OF-1
    B4895 OF-1
    Summary: BRPF1B and BRPF2 bromodomain inhibitor
      insoluble in H2O; insoluble in EtOH; ≥14.55 mg/mL
  3. BMH-21
    B4896 BMH-21
    Target: RNA Polymerases
    Summary: RNA polymerase I Inhibitior
      insoluble in EtOH; insoluble in H2O; ≥7.4 mg/mL
  4. CCG-1423
    B4897 CCG-1423
    Target: Rho
    Summary: RhoA inhibitor
      ≥21 mg/mL
  5. Bikinin
    B4898 Bikinin
    Target: GSK-3
    Summary: GSK3 inhibitor and Brassinosteroid activator
      insoluble in H2O; ≥13.65 mg/mL
  6. BLZ945
    B4899 BLZ945
     1 Citation
    Target: CSF-1R
    Summary: CSF-1R kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.9 mg/mL
  7. Indoximod (NLG-8189)
    B4900 Indoximod (NLG-8189)
    Summary: Indoleamine 2,3-dioxygenase (IDO) pathway inhibitor
      insoluble in DMSO; insoluble in EtOH; ≥1.12 mg/mL
  8. (+)-Apogossypol
    B4902 (+)-Apogossypol
    Target: Bcl-2
    Summary: inhibitor of Bcl-2 family proteins
      insoluble in H2O; ≥16.2 mg/mL
  9. CX-4945 sodium salt
    B4903 CX-4945 sodium salt
    Summary: CK2 inhibitor
      ≥44.2 mg/mL
  10. ACTB-1003
    B4904 ACTB-1003
    Target: VEGFR|FGFR|Tie-2|RSK|p70 S6K
    Summary: FGFR1 inhibitor
      insoluble in H2O; ≥18.15 mg/mL

Items 601-610 of 9364

Page
per page